COVID-19 in Polish Ice Swimmers.
ICE
Influence of Ice Swimming on Hardening Against SARS-CoV-2 and Influence of AB0 Rh Blood Type on Viral Resistance in Polish Ice Swimmers.
1 other identifier
observational
2,534
1 country
3
Brief Summary
Ice swimming is an increasingly common phenomenon in Poland. It has been confirmed that it has a beneficial effect on health by increasing the natural non-specific immunity to infections. In the face of the current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic causing Coronavirus Disease 2019 (COVID-19), researchers decided to use a survey to check the incidence of COVID-19 among Polish ice swimmers, as well as recent ailments. Then, the researchers will compare the obtained results with epidemiological data for Poland.Researchers will also investigate the relationship between susceptibility to SARS-CoV-2 infection and the blood group and Rh factor among ice swimmers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 24, 2021
CompletedFirst Posted
Study publicly available on registry
March 26, 2021
CompletedApril 9, 2021
April 1, 2021
2 months
March 24, 2021
April 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.
Inference from data obtained from surveys collected among ice swimmers.
47 days.
Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.
Inference from data obtained from surveys collected among ice swimmers.
47 days.
Secondary Outcomes (1)
Assessment of the immunity of the ice swimmer's immune system compared to the general population.
47 days.
Study Arms (1)
Ice Swimmers Group.
No intervention. Data obtained from Polish ice swimmers reported by them retrospectively in the questionnaire.
Interventions
The intervention is not made in the course of a research study. Ice swimming has been introduced earlier by a given group. The group was made up of people who already swim in ice.
Eligibility Criteria
Surveys are distributed en masse among ice swimmers from Poland. Comparative data for the control group is derived from officially published national and regional pandemic data.
You may qualify if:
- ice swimmers
You may not qualify if:
- not active ice swimmers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Department of Public Health at Wroclaw Medical University
Wroclaw, Dolny Slask, 51-618, Poland
Department of Radiotherapy of Multidisciplinary Provincial Hospital
Gorzów Wielkopolski, Lubusz Voivodeship, 66-400, Poland
Treasury Medical Company
Zielona Góra, Lubusz Voivodeship, 65-031, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sylwia Sulimiera Michalak, MD, PhD
Department of Pharmacology and Toxicology, Medical University of Zielona Gora
- STUDY DIRECTOR
Edyta Wolny-Rokicka, MD, PhD
Department and Center of Radiotherapy, Multidisciplinary Provincial Hospital in Gorzow Wielkopolski
- STUDY CHAIR
Andrzej Tukiendorf, Prof.
Department of Public Health, Wroclaw Medical University
- PRINCIPAL INVESTIGATOR
Lukasz K Wysoczanski, MD
Department of Family Medicine, Wroclaw Medical University
- PRINCIPAL INVESTIGATOR
Paulina N Wysoczanska, MD
Department of Family Medicine, Wroclaw Medical University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2021
First Posted
March 26, 2021
Study Start
December 1, 2020
Primary Completion
January 17, 2021
Study Completion
March 1, 2021
Last Updated
April 9, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share